These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 22156972)

  • 21. Survival and prognostic factors of HIV-infected patients with HCV-related end-stage liver disease.
    Merchante N; Girón-González JA; González-Serrano M; Torre-Cisneros J; García-García JA; Arizcorreta A; Ruiz-Morales J; Cano-Lliteras P; Lozano F; Martínez-Sierra C; Macías J; Pineda JA;
    AIDS; 2006 Jan; 20(1):49-57. PubMed ID: 16327319
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Suboptimal performance of APRI and FIB-4 in ruling out significant fibrosis and confirming cirrhosis in HIV/HCV co-infected and HCV mono-infected patients.
    Mazzola G; Adamoli L; Calvaruso V; Macaluso FS; Colletti P; Mazzola S; Cervo A; Trizzino M; Di Lorenzo F; Iaria C; Prestileo T; Orlando A; Di Marco V; Cascio A
    Infection; 2019 Jun; 47(3):409-415. PubMed ID: 30519966
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Does Incorporating Change in APRI or FIB-4 Indices Over Time Improve the Accuracy of a Single Index for Identifying Liver Fibrosis in Persons With Chronic Hepatitis C Virus Infection?
    Gounder PP; Haering C; Bruden DJT; Townshend-Bulson L; Simons BC; Spradling PR; McMahon BJ
    J Clin Gastroenterol; 2018 Jan; 52(1):60-66. PubMed ID: 27875352
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevalence of and progression to abnormal noninvasive markers of liver disease (aspartate aminotransferase-to-platelet ratio index and Fibrosis-4) among US HIV-infected youth.
    Kapogiannis BG; Leister E; Siberry GK; Van Dyke RB; Rudy B; Flynn P; Williams PL;
    AIDS; 2016 Mar; 30(6):889-98. PubMed ID: 26959353
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fibrosis index based on four factors better predicts advanced fibrosis or cirrhosis than aspartate aminotransferase/platelet ratio index in chronic hepatitis C patients.
    Wang CC; Liu CH; Lin CL; Wang PC; Tseng TC; Lin HH; Kao JH
    J Formos Med Assoc; 2015 Oct; 114(10):923-8. PubMed ID: 26279173
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluating Noninvasive Markers to Identify Advanced Fibrosis by Liver Biopsy in HBV/HIV Co-infected Adults.
    Sterling RK; King WC; Wahed AS; Kleiner DE; Khalili M; Sulkowski M; Chung RT; Jain MK; Lisker-Melman M; Wong DK; Ghany MG;
    Hepatology; 2020 Feb; 71(2):411-421. PubMed ID: 31220357
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Liver fibrosis progression and clinical outcomes are intertwined: role of CD4+ T-cell count and NRTI exposure from a large cohort of HIV/HCV-coinfected patients with detectable HCV-RNA: A MASTER cohort study.
    Focà E; Fabbiani M; Prosperi M; Quiros Roldan E; Castelli F; Maggiolo F; Di Filippo E; Di Giambenedetto S; Gagliardini R; Saracino A; Di Pietro M; Gori A; Sighinolfi L; Pan A; Postorino MC; Torti C;
    Medicine (Baltimore); 2016 Jul; 95(29):e4091. PubMed ID: 27442636
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Evaluation of APRI score in liver disease following the introduction of antiretroviral therapy in HIV and HCV coinfected versus HIV monoinfected patients].
    Antonello VS; Tovo CV; Kliemann DA; Santos BR; Zaltron VF
    Rev Soc Bras Med Trop; 2010; 43(6):678-81. PubMed ID: 21181022
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reproductive Aging and Hepatic Fibrosis Progression in Human Immunodeficiency Virus/Hepatitis C Virus-Coinfected Women.
    Sarkar M; Dodge JL; Greenblatt RM; Kuniholm MH; DeHovitz J; Plankey M; Kovacs A; French AL; Seaberg EC; Ofotokun I; Fischl M; Overton E; Kelly E; Bacchetti P; Peters MG;
    Clin Infect Dis; 2017 Oct; 65(10):1695-1702. PubMed ID: 29020239
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Do serum markers of liver fibrosis vary by HCV infection in patients with alcohol use disorder?
    Sanvisens A; Muñoz A; Bolao F; Zuluaga P; Farré M; Jarrin I; Tor J; Muga R
    Drug Alcohol Depend; 2018 Jul; 188():180-186. PubMed ID: 29778771
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Roles of Fibrosis Index Based on Four Factors and Aspartate Transaminase-to-Platelet Ratio Index Scoring Systems as an Alternative to Transient Elastography Liver Stiffness in Liver Fibrosis Staging in Human Immunodeficiency Virus and Hepatitis C Virus Co-Infected Patients.
    Ajao S; Roach D; Chan KH; Thimmanagari K; Muhanna A; Mutyala M; Lakasanni S; Slim J
    Gastroenterology Res; 2021 Aug; 14(4):209-213. PubMed ID: 34527089
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Marijuana Use Is Not Associated With Progression to Advanced Liver Fibrosis in HIV/Hepatitis C Virus-coinfected Women.
    Kelly EM; Dodge JL; Sarkar M; French AL; Tien PC; Glesby MJ; Golub ET; Augenbraun M; Plankey M; Peters MG
    Clin Infect Dis; 2016 Aug; 63(4):512-8. PubMed ID: 27225241
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of lifetime alcohol use on liver fibrosis in a population of HIV-infected patients with and without hepatitis C coinfection.
    Fuster D; Tsui JI; Cheng DM; Quinn EK; Bridden C; Nunes D; Libman H; Saitz R; Samet JH
    Alcohol Clin Exp Res; 2013 Sep; 37(9):1527-35. PubMed ID: 23647488
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of HIV-1 Infection on the Natural Progress of an Anti-HCV Positive Population in an Impoverished Village in China from 2009 to 2017.
    Li X; Li Y; Zhang Y; Yin Y; Tu J; Xu Q; Liang H; Shen T
    Viruses; 2022 Jul; 14(8):. PubMed ID: 35893687
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hepatitis C co-infection and severity of liver disease as risk factors for osteoporotic fractures among HIV-infected patients.
    Maalouf NM; Zhang S; Drechsler H; Brown GR; Tebas P; Bedimo R
    J Bone Miner Res; 2013 Dec; 28(12):2577-83. PubMed ID: 23677838
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antiretroviral treatment interruption leads to progression of liver fibrosis in HIV-hepatitis C virus co-infection.
    Thorpe J; Saeed S; Moodie EE; Klein MB;
    AIDS; 2011 Apr; 25(7):967-75. PubMed ID: 21330904
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biochemical non-invasive assessment of liver fibrosis cannot replace biopsy in HIV-HCV coinfected patients.
    Kliemann DA; Wolff FH; Tovo CV; Alencastro PR; Ikeda ML; Brandão AB; Barcellos N; Fuchs SC
    Ann Hepatol; 2016; 15(1):27-32. PubMed ID: 26626637
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Brief Report: HIV/HBV Coinfection is a Significant Risk Factor for Liver Fibrosis in Tanzanian HIV-Infected Adults.
    Hawkins C; Christian B; Fabian E; Macha I; Gawile C; Mpangala S; Ulenga N; Thio CL; Ammerman LR; Mugusi F; Fawzi W; Green R; Murphy R
    J Acquir Immune Defic Syndr; 2017 Nov; 76(3):298-302. PubMed ID: 29016448
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prediction of liver stiffness by serum indexes in HCV-infected patients with or without HIV coinfection.
    Merchante N; Mena Á; Pascasio JM; Marco A; Rodriguez M; Hernandez-Guerra M; Simón MA
    Medicine (Baltimore); 2021 Nov; 100(46):e27838. PubMed ID: 34797315
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Advanced liver fibrosis by transient elastography, fibrosis 4, and alanine aminotransferase/platelet ratio index among Asian hepatitis C with and without human immunodeficiency virus infection: role of vitamin D levels.
    Avihingsanon A; Jitmitraparp S; Tangkijvanich P; Ramautarsing RA; Apornpong T; Jirajariyavej S; Putcharoen O; Treeprasertsuk S; Akkarathamrongsin S; Poovorawan Y; Matthews GV; Lange JM; Ruxrungtham K;
    J Gastroenterol Hepatol; 2014 Sep; 29(9):1706-14. PubMed ID: 24730732
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.